Institute for Applied Cancer Science
Alexei Protopopov, Ph.D. - Associate Director, Oncogenomics
Alexei Protopopov, Ph.D., joined MD Anderson after more than a decade of cancer genetics research at Dana-Farber Cancer Institute and Karolinska Institute. During his career, he oversaw several genomic data production programs including leading the Arthur and Rochelle Belfer Center for Cancer Genomics in Dana-Farber and being served as a program manager/core director of The Cancer Genome Atlas' Genome Characterization Center at Harvard Medical School/MDACC. He pioneered multiple methods of molecular cytogenetics, genomics and epigenetics, also has extensive experience in scaling up characterization pipelines and QA/QC.
His research focusing specifically on preclinical models, tumor microenvironment and genome evolution has resulted in a hundred of publications in peer-reviewed journals, including Nature and Science.
Protopopov received his Ph.D. in biophysics (cell and molecular biology) from the Institute of Biophysics, Russia, then trained in tumor biology and completed his post-doctoral research in the laboratory of Professor George Klein at Karolinska Institute, Sweden.